Page last updated: 2024-08-21

ethyl pyruvate and Neoplasm Metastasis

ethyl pyruvate has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beer-Stolz, D; Davé, SH; DeMarco, RA; Fink, MP; Li, F; Lotze, MT; Matsuoka, K; Plevy, SE; Sepulveda, AR; Tilstra, JS1

Other Studies

1 other study(ies) available for ethyl pyruvate and Neoplasm Metastasis

ArticleYear
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.
    Journal of leukocyte biology, 2009, Volume: 86, Issue:3

    Topics: Adenocarcinoma; Animals; Annexin A5; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colitis; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein-5-isothiocyanate; HMGB1 Protein; In Situ Nick-End Labeling; Interleukin-10; Interleukin-12 Subunit p40; Intestinal Mucosa; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Pyruvates; Random Allocation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transfection

2009